MENU

NEUE Stock NeueHealth (NEUE, $6.87) entered Downtrend as Momentum indicator drops below 0 level on May 30, 2025

A.I.dvisor
at Tickeron.com
Loading...
NEUE - NeueHealth
Momentum signal
Bearish Trend
Odds of DOWN Trend
Tickeron
Momentum signal
Price: $6.87
Daily change: +$0.02 (+0.29%)
Daily volume: 3.7K
Capitalization: $61.3M
Industry: Managed Health Care
This indicator may be signaling that NEUE's price has further to drop, since it fell below its price logged 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options. A.I.dvisor backtested 79 similar cases where NEUE's Momentum Indicator fell below the 0 level, and of them led to a successful outcome. Odds of Success:

NEUE saw its Stochastic Oscillator peaks and leaves the overbought zone

The Stochastic Oscillator for NEUE moved out of overbought territory on May 20, 2025. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 35 similar instances where the indicator exited the overbought zone. In of the 35 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for NEUE turned negative on May 20, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 27 similar instances when the indicator turned negative. In of the 27 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NEUE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 04, 2025. You may want to consider a long position or call options on NEUE as a result. In of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NEUE advanced for three days, in of 189 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 57 cases where NEUE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: NEUE's P/B Ratio (0.000) is slightly lower than the industry average of (3.063). NEUE's P/E Ratio (0.000) is considerably lower than the industry average of (17.509). NEUE's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.089). NEUE has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.020). NEUE's P/S Ratio (0.043) is slightly lower than the industry average of (0.684).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NEUE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NEUE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.

View a ticker or compare two or three
NEUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry ManagedHealthCare

Profile
Fundamentals
Details
Industry
N/A
Address
9250 NW 36th Street
Phone
+1 612 238-1321
Employees
2840
Web
https://www.neuehealth.com